Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxidex and Patanol in Allergic Conjunctivitis EEC Model
NCT01119287Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2010
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, olopatadine in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Mar 2010; status: completed.
02
Drugs
dexamethasoneolopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01119287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119287.